Human Health and Potential (HHP)

A*STAR researchers explore mushroom extracts as healthy fat substitutes to boost the nutritional profiles of meat products.

An experimental antibody therapy for solid tumours in adults also shows promise in improving quality of life for paediatric patients.

Research reveals that the way we chew can affect our blood sugar levels, offering improved strategies for managing blood sugar in people at risk for type 2 diabetes.

A polymer-based drug delivery innovation can replace invasive eye treatments for retinal diseases.

A*STAR researchers explore the potential and challenges associated with meat-free protein sources for a sustainable, healthier global diet.

A programmable gene editing tool targets and eliminates a rapidly mutating RNA virus responsible for hand, foot and mouth disease.

In a breakthrough study, researchers identify how an enzyme found in fungi produces a natural chemical commonly used in cosmetics, fragrances and medicines.

While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals, researchers find that mixed mRNA vaccines may offer a vital boost of protection.

A new portable diagnostic technology promises unparalleled speed, accuracy and clinical utility for ovarian cancer diagnoses.

Researchers reveal how disrupting a key genetic control mechanism can significantly hinder the progression and spread of an aggressive and difficult-to-treat form of breast cancer.

A*STAR researchers identified the mechanism behind how a common gene mutation in kidney cancer impacts chromatin remodelling and drives tumour development, opening up new possibilities for therapeutic interventions.

A*STAR researchers tackle the challenge of creating therapeutic antibodies that effectively kill tumours and are also easily scalable in manufacturing settings.